It is also used to treat Staphylococcus aureus bacteremia once identified on blood culture and S. aureus bone or joint infections.21 In a randomized trial involving 200 patients with complicated S. aureus bacteremia, 2 doses of intravenous dalbavancin were noninferior to 4 to 8 weeks of other
Stevenson et al. (Sun,) studied this question.